1 |
Omata M, Cheng A, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update [J]. Hepatol Int, 2017, 11(4): 317-370.
|
2 |
Galle PR, Forner A, Llovet JM, et al. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma [J]. J Hepatol, 2018, 69(1): 182-236.
|
3 |
Aube C, Oberti F, Lonjon J, et al. EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice [J]. Liver Int, 2017, 37(10): 1515-1525.
|
4 |
International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia [J]. Hepatology, 2009, 49(2): 658-664.
|
5 |
Sato T, Kondo F, Ebara M, et al. Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study [J]. Hepatol Int, 2015, 9(2): 330-336.
|
6 |
Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS [J]. Ultraschall Med, 2013, 34(1): 11-29.
|
7 |
Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma [J]. Hepatology, 2018, 67(1): 358-380.
|
8 |
Jang HJ, Kim TK, Burns PN, et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: Comparison with histologic differentiation [J]. Radiology, 2007, 244(3): 898-906.
|
9 |
Chou CT, Chou JM, Chang TA, et al. Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging [J]. World J Gastroenterol, 2013, 19(42): 7433-7439.
|
10 |
Takahashi M, Maruyama H, Ishibashi H, et al. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma [J]. AJR Am J Roentgenol, 2011, 196(2): 123-131.
|
11 |
Di Martino M, Anzidei M, Zaccagna F, et al. Qualitative analysis of small (≤2 cm) regenerative nodules, dysplastic nodules and well-differentiated HCCs with gadoxetic acid MRI [J]. Bmc Med Imaging, 2016, 16(1): 62.
|
12 |
严福华, 周康荣, 沈继章, 等. MR和CT动态扫描对小肝癌强化特征的比较研究 [J]. 中华肿瘤杂志, 2001, 23(5): 413-416.
|
13 |
Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images [J]. Radiology, 2007, 242(1): 162-174.
|
14 |
Shin SK, Kim YS, Choi SJ, et al. Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis [J]. Dig Liver Dis, 2015, 47(9): 775-782.
|
15 |
Park YN, Yang CP, Fernandez GJ, et al. Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver [J]. Am J Surg Pathol, 1998, 22(6): 656-662.
|
16 |
林满霞, 徐辉雄, 谢晓燕, 等. 肝硬化基础上低度和高度不典型增生结节的超声造影表现 [J]. 中华超声影像学杂志, 2009, 18(12): 1057-1060.
|
17 |
黄斌, 孙希希, 荀运浩, 等. 常规二维超声联合超声造影对肝硬化背景肝内结节分类及临床应用价值 [J/CD]. 中华医学超声杂志(电子版), 2017, 14(4): 297-301.
|
18 |
Kim BR, Lee JM, Lee DH, et al. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging versus multidetector CT in the detection of dysplastic nodules and early hepatocellular carcinoma [J]. Radiology, 2017, 285(1): 134-146.
|
19 |
Ohama H, Imai Y, Nakashima O, et al. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI [J]. J Gastroenterol, 2014, 49(6): 1081-1093.
|
20 |
Sangiovanni A, Manini MA, Iavarone M, et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis [J]. Gut, 2010, 59(5): 638-644.
|